WallStreetZenWallStreetZen

NASDAQ: INCR
Intercure Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

INCR past revenue growth

How has INCR's revenue growth performed historically?
Company
95.18%
Industry
253.41%
Market
17.29%
INCR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INCR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INCR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INCR earnings and revenue history

Current Revenue
$101.9M
Current Earnings
$9.3M
Current Profit Margin
9.2%

INCR Return on Equity

Current Company
7.4%
Current Industry
12.4%
Current Market
-9.5%
INCR's Return on Equity (7.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INCR announces earnings.

INCR Return on Assets

Current Company
4.3%
Current Industry
3.8%
INCR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INCR Return on Capital Employed

Current Company
10.02%
Current Industry
7.9%

INCR vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INCR$104.25M$18.42M$9.54M+95.18%N/A
MNKN/AN/AN/AN/AN/A
SLDB$8.09M-$83.57M-$85.98M-40.57%N/A
SCTL$90.21M$3.60M-$19.88M+4.66%N/A
DRRX$19.28M-$32.82M-$35.33M-17.07%N/A
View Top Pharmaceutical Stocks

INCR earnings dates

Next earnings date
May 15, 2023

Intercure Earnings & Revenue FAQ

What were INCR's earnings last quarter?

On Invalid Date, Intercure (NASDAQ: INCR) reported Q3 2022 earnings per share (EPS) of $0.05, up 475% year over year. Total Intercure earnings for the quarter were $2.04 million. In the same quarter last year, Intercure's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Intercure stock.

What was INCR's earnings growth in the past year?

As of Q1 2023, Intercure's earnings has grown year over year. Intercure's earnings in the past year totalled $9.54 million.

What is INCR's earnings date?

Intercure's earnings date is Invalid Date. Add INCR to your watchlist to be reminded of INCR's next earnings announcement.

What was INCR's revenue last quarter?

On Invalid Date, Intercure (NASDAQ: INCR) reported Q3 2022 revenue of $28.25 million up 46.53% year over year. In the same quarter last year, Intercure's revenue was $19.28 million.

What was INCR's revenue growth in the past year?

As of Q1 2023, Intercure's revenue has grown 95.18% year over year. This is 158.22 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 253.41%. Intercure's revenue in the past year totalled $104.25 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.